Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Signature Genomic Laboratories LLC

Division of PerkinElmer Inc.
www.signaturegenomics.com

Latest From Amira Medical

Two Rising Stars in Glucose Testing

Despite its attraction, diabetes glucose monitoring remains a tough field for newcomers, who face competition from four major-league, entrenched players. But two of the newer entrants appear to be succeeding--not because of revolutionary technology, but because of partnering savvy, efficient execution, and technological competence. Analysts expect Inverness Medical's symbiotic relationship with LifeScan to help Inverness's diabetes sales grow 30% a year as LifeScan pushes Inverness-made products as a major part of its fight to regain its market leadership. Home Diagnostics Inc.'s success with co-branding raises the prospect that discounting, until now not a significant factor, will become much more common in the field.
Medical Device Strategy

A Robust IPO Market--even for Devices?

Anyone who stood in the packed room at this year's Chase Hambrecht & Quist meeting in San Francisco in early January for the presentation by e-commerce player Neoforma.com Inc. could hardly be surprised by the results of the company's IPO, which went out the week following, raising $91 million for the B2B supply chain manager. But as well as the Neoforma public offering did, it was, arguably, nothing compared to the IPO of Aspect Medical Systems Inc., a manufacturer of depth-of-anesthesia monitoring devices.
Medical Device Leadership

Just Around the Corner: Pursuing the Elusive Diabetes Market

Diabetes seems like a great clinical and commercial opportunity but it's been a technological nightmare for many small device and diagnostic companies. Still, there's enough good news coming out of R&D to keep entrepreneurs going
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
  • Therapeutic Areas
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • PerkinElmer Inc.
  • Senior Management
  • Lisa G Shaffer, PhD, Pres.
    Bassem A Bejjani, MD, CMO
    Blake C Ballif, PhD, Dir., Prod. Dev. & Research
  • Contact Info
  • Signature Genomic Laboratories LLC
    Phone: (509) 474-6840
    2820 N. Astor St.
    Spokane, WA 99207
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register